Jeevan Scientific Technology Limited's Bioavailability/Bioequivalence (BA/BE) Study Centre has successfully completed an inspection by the Central Drugs Standard Control Organization.

This inspection was a crucial part of the company's application to add more beds to its existing approved BA/BE center in Hyderabad.

The successful conclusion of this regulatory evaluation is a significant step towards expanding the center's capacity, enhancing the company's operational capabilities and future growth potential in clinical research services.

This development is positive for stakeholders as it indicates progress in scaling business operations.